Use and effectiveness of dapagliflozin in routine clinical practice: An Italian multicentre retrospective study

In randomized controlled trials (RCTs), sodium‐glucose co‐transporter‐2 (SGLT2) inhibitors have been shown to confer glycaemic and extra‐glycaemic benefits. The DARWIN‐T2D (DApagliflozin Real World evIdeNce in Type 2 Diabetes) study was a multicentre retrospective study designed to evaluate the base...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diabetes Obes Metab
Auteurs principaux: Fadini, Gian Paolo, Zatti, Giancarlo, Baldi, Ileana, Bottigliengo, Daniele, Consoli, Agostino, Giaccari, Andrea, Sesti, Giorgio, Avogaro, Angelo
Format: Artigo
Langue:Inglês
Publié: Blackwell Publishing Ltd 2018
Sujets:
Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6175069/
https://ncbi.nlm.nih.gov/pubmed/29516612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13280
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires